Courtney M. Hetrick

Courtney M. Hetrick

Courtney M. Hetrick
+1 617 570 3953

Courtney Hetrick is a partner in the firm's Business Law Department and a member of its Technology & Life Sciences group. She joined Goodwin in 2012.

Ms. Hetrick represents public and private companies in all stages of maturity in the technology and life sciences industries. She counsels clients on a wide array of corporate matters, including entity formation, venture capital financings, public securities offerings, mergers and acquisitions, securities law compliance and strategic transactions.

Ms. Hetrick's representative matters include:

Capital Markets Transactions

  • Orchard Therapeutics in its $225.5 million initial public offering
  • AVROBIO in its $114.7 million initial public offering
  • ConforMIS in its $20 million follow-on offering with Cowen and Canaccord Genuity
  • scPharmaceuticals in its $90 million initial public offering
  • Stifel Nicolaus Weisel as an underwriter in Argos Therapeutics $41 million initial public offering
  • Repligen Corporation in its $115 million convertible note offering
  • Underwriting syndicate in the $64.8 million follow-on financing and subsequent $77 million follow-on financing for Flexion Therapeutics

Mergers and Acquisitions

  • Albany Molecular Research Inc. in its $1.7 billion (enterprise value) sale to The Carlyle Group and GTCR
  • iRobot Corporation in the sale of its Defense & Security business to Arlington Capital Partners
  • Zalicus Inc. in its sale to Epirus Biopharmaceuticals
  • Repligen Corporation in its acquisitions of (1) Refine Technology’s Alternating Tangential Flow (“ATF”) System, (2) Atoll GmbH, (3) TangenX Technology Corporation, 4) Spectrum, Inc., and (5) C Technologies
  • QPID Health in its sale to eviCore healthcare
  • Attend, an event software company, in its sale to Event Farm

Venture Capital Financing Transactions

  • Cabaletta Bio in its $38 million Series A financing transaction
  • Rheos Medicines in its $60 million Series A financing transaction
  • scPharmaceuticals in its $45.6 million Series B financing transaction
  • Barkly Protects in its $12.5 million Series A financing transaction

Professional Activities

Ms. Hetrick is an instructor of the “Forming and Financing a Start-Up Business” course at Boston University School of Law. She is a member of the American and Boston Bar Associations and the Women’s Bar Association.

Ms. Hetrick currently serves on the hiring committee for Goodwin’s Boston office.





University of Florida College of Law

(cum laude)

BS in Business Admin2009

Stonehill College



  • Massachusetts

Recognition & Awards

Ms. Hetrick was recognized as a Massachusetts Super Lawyer “Rising Star" for 2018 and 2019. 

While attending law school, Ms. Hetrick served as an articles editor on the Florida Law Review and received the Book Award in Business Associations Survey: Business Organizations and Corporations.



Ms. Hetrick's speaking engagements have included “Private Equity & Venture Capital Financing” for MCLE’s Corporate Practice series (2017, 2018, 2019). 

Ms. Hetrick is the author of “Some More Watters, Please: The Dodd-Frank Act’s New Preemption Standards Lighten Consumers’ Wallets” published in the Florida Law Review (December 2011).